IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#3954
Positioning
Market Dominance
Services
Business Services
$12M
Hong Zhida
Addentax Group Corp. operates through four segments: Garment, Logistics Services, Epidemic Prevention Supplies, and Property Management and Subleasing. The company manufactures garments; provides logistic services, such as storage, transportation, warehousing, handling, packaging, and order processing.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = ATXG ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$ATXG ADDENTAX GROUP CORP. | 37 | 30 | 19 | 23 | - | - | -25.0% | -19.2% | 20.7% | -36.0% | -134.1% | 14.7% | 0.0% | 31.0x | $12M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
ADDENTAX GROUP CORP. (ATXG) receives a "Avoid" rating with a composite score of 36.6/100. It ranks #3954 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Hong Zhida
Chief Executive Officer
Labor Force
130
30
50
39
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for ATXG
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
Average volatility — neutral timing signal
Moderate investment profile
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for ATXG.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 30 | 16 | +14ALPHA |
| MOMENTUM | 23 | 16 | +7ALPHA |
| VALUATION | 19 | 10 | +9ALPHA |
| INVESTMENT | 50 | 87 | -37DRAG |
| STABILITY | 39 | 35 | +4NEUTRAL |
| SHORT INT | 90 | 100 | -10DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -25.0% (sector 5.3%)
GM 21% vs sector 60%, OM -36% vs sector 4%
Capital turnover N/A
Rev growth 15%, 11yr history
Interest coverage -6.5x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags ADDENTAX GROUP CORP. with an Avoid rating, assigning a composite score of 36.6/100 and 1 out of 5 stars. Ranked #3954 of 7,333 stocks, ATXG falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
ATXG's quality score of 30/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -25.0% (sector avg: 5.3%), gross margins of 20.7% (sector avg: 59.6%), net margins of -134.1% (sector avg: 2.3%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
ATXG registers a value score of just 19/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 0.20x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
With an investment score of 50/100, ATXG exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 14.7% vs. a sector average of 7.8% and a return on assets of -19.2% (sector: 1.9%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
ADDENTAX GROUP CORP. is experiencing notably weak momentum with a score of just 23/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at 14.7% year-over-year, while a beta of 0.23 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
ATXG's stability score of 39/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 0.23 and a debt-to-equity ratio of 31.00x (sector avg: 0.3x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
ATXG's short interest factor score of 90/100 indicates very low short selling activity relative to peers — a positive signal suggesting institutional investors see limited near-term downside. Specific risk factors include elevated leverage (D/E: 31.00x), micro-cap liquidity risk. As a micro-cap company with a market capitalization of $12M, ADDENTAX GROUP CORP. benefits from the generally lower volatility and deeper liquidity associated with its size class.
ADDENTAX GROUP CORP. is a micro-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #3954 of 7,333 overall (46th percentile). Key comparisons include ROE of -25.0% trailing the 5.3% sector median and operating margins of -36.0% below the 3.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While ATXG currently exhibits a AVOID profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Value (19) would have the largest impact on the composite score.
ROE 571% BELOW SECTOR MEDIAN
Gross Margin 65% BELOW SECTOR MEDIAN
Op. Margin 1126% BELOW SECTOR MEDIAN
AUDIT DATA AS OF DEC 31, 2025 (Q3 FY2025)
We rate ADDENTAX GROUP CORP. (ATXG) as Avoid with a composite score of 36.6/100 at a current price of $0.35. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in investment (50th percentile) and stability (39th percentile), which together account for the majority of the composite score. Offsetting weakness in value (19th percentile) and momentum (23th percentile) tempers our overall conviction. We assign a No Moat rating (17/100), High uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; the path to profitability; valuation compression risk if growth disappoints. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
ADDENTAX GROUP CORP. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 36.6/100 places it at rank #3954 in our full 7,333-stock universe. At $12M in market capitalization, ADDENTAX GROUP CORP. is a small-cap player in the Services space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 15%, though momentum at the 23th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 21% (-38.9pp vs sector) narrow to operating margins of -36% (-39.5pp vs sector) and net margins of -134.1%, yielding a gross-to-net conversion rate of -648%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $0.35, ADDENTAX GROUP CORP. is trading at a premium to fundamental value. Our value factor score of 19/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/B of 0.2x, P/S of 1.1x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Revenue growth of 15% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
The Avoid rating (composite 36.6/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Thin net margins of -134.1% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Weak momentum (23th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
Below-average quality (30th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
We assign a High uncertainty rating to ADDENTAX GROUP CORP.. Key risk factors include current negative profitability (net margin -134.1%), below-average price stability (39th percentile), weak quality scores (30th percentile). The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: current negative profitability (net margin -134.1%); below-average price stability (39th percentile); weak quality scores (30th percentile); low beta of 0.23 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 39th percentile and quality factor at the 30th percentile provide a quantitative summary of the overall risk landscape.
We identify limited risk mitigants at this time, which contributes to our high uncertainty assessment. Investors should monitor for improvement in balance sheet metrics, margin stability, and business predictability that could warrant a downgrade in our risk assessment over time.
We rate ADDENTAX GROUP CORP.'s capital allocation as Poor. Key concerns include low returns on equity (-25.0%), negative profitability, weak asset returns (ROA -19.2%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — ADDENTAX GROUP CORP. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, ADDENTAX GROUP CORP. receives a Avoid rating with a composite score of 36.6/100 (rank #3954 of 7,333). Our quantitative framework assigns a No Moat (17/100, trend: stable), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 32/100.
Our analysis does not support a constructive view on ADDENTAX GROUP CORP. at this time. The combination of limited competitive advantages, high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign ADDENTAX GROUP CORP. a meaningful economic moat, scoring 17/100 on our composite assessment. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, financial resilience, reached only 7.3/20.
The strongest moat sources are financial resilience (7.3/20) and growth durability (6.5/20). Interest coverage -6.5x. Rev growth 15%, 11yr history. These pillars form the core of ADDENTAX GROUP CORP.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and margin superiority (0.4/20). Capital turnover N/A. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect ADDENTAX GROUP CORP.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include moderate revenue growth of 15%. The margin cascade from 21% gross to -36% operating to -134.1% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 30th percentile.
The margin profile shows gross margins of 21%, operating margins of -36%, net margins of -134.1%. Return metrics include ROE of -25.0% and ROA of -19.2%. Relative to the Services sector, gross margins are 38.9 percentage points below the sector median of 60%, and ROE of -25.0% compares to a sector median of 5.3%.
The balance sheet reflects moderate leverage with D/E of 31%, revenue growth of 15%. The sector median D/E is 0%, putting ADDENTAX GROUP CORP. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Elevated short interest (90th percentile) indicates that sophisticated market participants are betting against the stock.
Above 50MA
37.18%
Net New Highs
+51081
Key Insights The projected fair value for Addentax Group is US$1.22 based on 2 Stage Free Cash Flow to Equity With...

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock. Keefe, Bruyette & Woods analyst Michael Perito downgraded SoFi from a Market Perform rating to an Underperform rating and lowered the price target from $7.50 to $6.50, citing recent outperformance and a change in the analyst's model. SoFi Technologies shares dipped 12.8% to $8.41 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers NexImmune, Inc. (NASDAQ: NEXI) shares rose 150.8% to $6.14 after gaining over 6% on Tuesday. Trinity Place Holdings Inc. (NYSE: TPHS) rose gained 62.6% to $0.1857. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024. Sigma Additive Solutions, Inc.(NASDAQ: SASI) gained 60.3% to $4.65. Sigma Additive Solutions, announced in an 8-K Filing, the approval of the issuance of the shares of common stock in exchange for all the capital stock of NextTrip Holdings. ABVC BioPharma, Inc. (NASDAQ: ABVC) jumped 58.3% to $1.90. ABVC BioPharma and its subsidiary received $460 million from AiBtl BioPharma as the first milestone payment of global licensing fees. Sidus Space, Inc. (NASDAQ: SIDU) rose 48.4% to $10.35. Sidus Space secured NOAA approval to provide imaging services to government and commercial customers. Brera Holdings PLC (NASDAQ: BREA) shares gained 32.8% to $0.97. First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 31.2% to $5.01. Roth MKM raised price target on the stock to $40. Elicio Therapeutics, Inc. (NASDAQ: ELTX) gained 29% to $7.65. TDCX Inc. (NYSE: TDCX) gained 28% to $6.18 after it disclosed receiving a preliminary non-binding ...

Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024. Trinity Place shares jumped 80.1% to $0.2056 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Sigma Additive Solutions, Inc.(NASDAQ: SASI) gained 68.6% to $4.89 in pre-market trading. Sigma Additive Solutions was recently granted U.S. patent #11858207: Defect detection for additive manufacturing systems. Carbon Revolution Public Limited Company (NASDAQ: CREV) rose 36.8% to $31.88 in pre-market trading. Rail Vision Ltd. (NASDAQ: RVSN) shares rose 29.5% to $1.62 in pre-market trading after dipping over 15% on Tuesday. First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 25.9% to $4.81 in pre-market trading. Roth MKM raised price target on the stock to $40. China Liberal Education Holdings ...

Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share. Fresh Vine Wine, Inc. (NYSE: VINE) gained 70.1% to $0.3845. Fresh Vine Wine recently announced the appointment of Hitesh Dheri as Chief Financial Officer and Secretary. Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 65.1% to $6.32. Advanced Health Intelligence recently announced the implementation of an ADS ratio change. SQZ Biotechnologies Company (NYSE: SQZ) shares gained 46.1% to $0.3944 after declining 11% on Friday. IMAC Holdings, Inc. (NASDAQ: BACK) shares jumped 38.6% to $0.1524. Theralink recently signed definitive merger agreement to be acquired by IMAC Holdings. Canopy Growth Corporation (NASDAQ: CGC) gained 37% to $0.5337. Canopy Growth said that all conversions pursuant to the $100 million senior unsecured convertible debentures, sold to an institutional investor in February 2023, have been completed. Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 30.6% to $2.39. HC Wainwright & Co. initiated coverage on Ensysce Biosciences with a Buy rating and announced a price target of $9. Spark Networks SE (NASDAQ: LOV) rose 26.1% to $0.3974. Nemaura Medical Inc. (NASDAQ: NMRD) surged 24.6% to $1.16. Ventyx Biosciences, Inc. (NASDAQ: VTYX) gained 17.6% to $38.56. Journey Medical Corporation (NASDAQ: DERM) jumped 17.6% to $1.87. Journey Medical expects topline results from the Phase 3 clinical trials evaluating DFD-2 for the treatment of papulopustular rosacea to be announced week of July 10, 2023. ACM Research, Inc. (NASDAQ: ACMR) shares climbed 17% to $15.30 after Jefferies upgraded its rating from Underperform to Buy and raised the price target from $9 to $23.4. Micromobility.com Inc. (NASDAQ: MCOM) shares ...

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms. CymaBay Therapeutics, Inc. (NASDAQ: CBAY) surged 40% to $10.97. Cyteir Therapeutics, Inc. (NASDAQ: CYT) shares gained 38% to $2.6487. Cyteir Therapeutics reported discontinuation of CYT-0851 development program and planned liquidation and dissolution. TOP Financial Group Limited (NASDAQ: TOP) shares gained 32.2% to $10.31 after the company reported FY23 financial results. Renalytix Plc (NASDAQ: RNLX) shares jumped 31% to $2.66 after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test. Baudax Bio, Inc. (NASDAQ: BXRX) gained 24% to $0.6450 after the company agreed to acquire TeraImmune in a stock-for-stock transaction. Friedman Industries, Incorporated (NYSE: FRD) rose 19.6% to $11.90 after posting a profit for the fourth quarter. CytomX Therapeutics, Inc. (NASDAQ: CTMX) gained 17.7% to $1.65 after the company announced a $30 million private placement from BVF Partners L.P. Rackspace Technology, Inc. (NASDAQ: RXT) gained 15.8% to $2.27. Rackspace Technology partnered with Google Cloud to offer cutting-edge generative AI services and solutions using the FAIR practice. Applied Optoelectronics, Inc. (NASDAQ: AAOI) gained 15.5% to $6.27. MicroVision, Inc. (NASDAQ: MVIS) climbed 12.8% to $4.40. XPeng Inc. (NYSE: XPEV) gained 12.4% to $13.29 after CLSA upgraded the stock from Buy to Outperform and raised the price target from $10 to $13.1. The company, on Thursday. launched G6 Ultra Smart Coupe ...